Correlation Between Cns Pharmaceuticals and Celularity
Can any of the company-specific risk be diversified away by investing in both Cns Pharmaceuticals and Celularity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cns Pharmaceuticals and Celularity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cns Pharmaceuticals and Celularity, you can compare the effects of market volatilities on Cns Pharmaceuticals and Celularity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cns Pharmaceuticals with a short position of Celularity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cns Pharmaceuticals and Celularity.
Diversification Opportunities for Cns Pharmaceuticals and Celularity
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Cns and Celularity is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Cns Pharmaceuticals and Celularity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Celularity and Cns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cns Pharmaceuticals are associated (or correlated) with Celularity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Celularity has no effect on the direction of Cns Pharmaceuticals i.e., Cns Pharmaceuticals and Celularity go up and down completely randomly.
Pair Corralation between Cns Pharmaceuticals and Celularity
Given the investment horizon of 90 days Cns Pharmaceuticals is expected to under-perform the Celularity. But the stock apears to be less risky and, when comparing its historical volatility, Cns Pharmaceuticals is 2.7 times less risky than Celularity. The stock trades about -0.09 of its potential returns per unit of risk. The Celularity is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 214.00 in Celularity on October 22, 2024 and sell it today you would earn a total of 16.00 from holding Celularity or generate 7.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cns Pharmaceuticals vs. Celularity
Performance |
| Timeline |
| Cns Pharmaceuticals |
| Celularity |
Cns Pharmaceuticals and Celularity Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cns Pharmaceuticals and Celularity
The main advantage of trading using opposite Cns Pharmaceuticals and Celularity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cns Pharmaceuticals position performs unexpectedly, Celularity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celularity will offset losses from the drop in Celularity's long position.| Cns Pharmaceuticals vs. ZyVersa Therapeutics | Cns Pharmaceuticals vs. Immix Biopharma | Cns Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Cns Pharmaceuticals vs. Ocean Biomedical |
| Celularity vs. Immix Biopharma | Celularity vs. ZyVersa Therapeutics | Celularity vs. Hepion Pharmaceuticals | Celularity vs. Cns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |